Next generation immunotherapies
for hard-to-treat cancers.
Addressing the shortcomings of current T cell-based immunotherapies
with powerful, targeted, safe technology.
Proprietary platforms allow for powerful controllability of CAR-T reactivity while maintaining high anti-tumor activity that prevents T-effector cell exhaustion and immune-suppression.
Switchable on/off mechanism made possible by combining a universal effector cell with soluble adaptors called Targeting Modules (TMs) allows for precise targeting of cancer antigens.
Rapid switchability lowers the risk for acute and long-term CRS-related and other side effects, opening a potentially improved therapeutic window for clinical application and increased safety.
Our mission is to overcome the limitations of current CAR-T cell therapies by introducing the next generation of immunotherapies to patients, everywhere.
Our proprietary Universal Switchable CAR and Allogeneic platforms promise significant advantages over current immunotherapies with improved therapeutic windows and outcomes.
Behind all that we do at AvenCell is our distinguished board of the industry’s top experts. They bring years of experience to the company and help shape, guide, and position AvenCell for continued success.
©2023 AvenCell Therapeutics, Inc. All Rights Reserved.
VP, Clinical Operations
Susan is the Vice President, Clinical Operations for Avencell; she brings over 30 years of experience in Global Clinical Operations to AvenCell’s Clinical Operations team. Prior to joining Avencell, Susan had multiple senior level roles within the Biotech, Pharmaceutical and CRO organizations. Susan has experience in leading clinical operations teams to successful study execution and multiple global regulatory submissions. Susan is a graduate of the University of Wisconsin-Milwaukee with a Bachelor of Science in Medical Technology.
Chief Executive Officer
Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you.
Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you. Want to discuss my work or a challenge you’re facing? Leave your details and I’ll get back to you.